NVO is a great company and one of the most thematic picks for this message board. However, I'm holding out for a better read on the uptake of insulin biosimilars in major markets.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.